BIO-TECHNE Corp vs VF Corp — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while VF Corp trades at $16.88 (market cap $6.62B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and VF Corp pays the higher dividend (2.13%). Which is the better fit depends on your goals.
| TECH | VFC | |
|---|---|---|
Market Cap | $11.16B | $6.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $72.12 | $21.55 |
52-Week Low | $43.31 | $11.66 |
Enterprise Value | $11.24B | $10.77B |
Dividend Yield | 0.45% | 2.13% |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →